ZIOP - ZIOPHARM Oncology, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5930.52M
Enterprise Value 3868.12M
Trailing P/E 5.87
Forward P/E 1-23.88
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)
Price/Book (mrq)12.40
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-17.11

Trading Information

Stock Price History

Beta (3Y Monthly) 2.87
52-Week Change 381.85%
S&P500 52-Week Change 37.70%
52 Week High 36.30
52 Week Low 31.56
50-Day Moving Average 35.21
200-Day Moving Average 33.79

Share Statistics

Avg Vol (3 month) 31.86M
Avg Vol (10 day) 31.31M
Shares Outstanding 5142.65M
Float 129.26M
% Held by Insiders 12.12%
% Held by Institutions 144.18%
Shares Short (Jun 28, 2019) 444.52M
Short Ratio (Jun 28, 2019) 416.85
Short % of Float (Jun 28, 2019) 428.00%
Short % of Shares Outstanding (Jun 28, 2019) 427.41%
Shares Short (prior month May 31, 2019) 441.05M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 240/1
Last Split Date 3Aug 24, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-37.53%
Return on Equity (ttm)-100.95%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-33.99M
EBITDA -50.73M
Net Income Avi to Common (ttm)144.95M
Diluted EPS (ttm)0.98
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)51.49M
Total Cash Per Share (mrq)0.32
Total Debt (mrq)1.59M
Total Debt/Equity (mrq)2.14
Current Ratio (mrq)8.89
Book Value Per Share (mrq)0.46

Cash Flow Statement

Operating Cash Flow (ttm)-40.73M
Levered Free Cash Flow (ttm)-29.81M